CDCA4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.417200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.799200E-01
Normal-vs-Stage2
5.638600E-01
Normal-vs-Stage3
8.659000E-01
Normal-vs-Stage4
7.137800E-01
Stage1-vs-Stage2
6.276400E-03
Stage1-vs-Stage3
5.703800E-01
Stage1-vs-Stage4
2.607800E-01
Stage2-vs-Stage3
7.054400E-01
Stage2-vs-Stage4
8.432600E-01
Stage3-vs-Stage4
9.141200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.053600E-01
Normal-vs-AfricanAmerican
6.439800E-01
Normal-vs-Asian
7.934400E-01
Caucasian-vs-AfricanAmerican
2.415800E-01
Caucasian-vs-Asian
5.399600E-01
AfricanAmerican-vs-Asian
3.932000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.743800E-01
Normal-vs-Female
6.122200E-01
Male-vs-Female
5.362400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.740600E-01
Normal-vs-Age(41-60Yrs)
5.334800E-01
Normal-vs-Age(61-80Yrs)
7.112400E-01
Normal-vs-Age(81-100Yrs)
5.232600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.483000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.397400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.524000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.926200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.819200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.410400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.403600E-01
Normal-vs-Daily Drinker
4.523200E-01
Normal-vs-Weekly Drinker
5.565000E-01
Normal-vs-Occasional Drinker
4.202800E-01
Normal-vs-Social Drinker
6.064000E-01
Non Drinker-vs-Daily Drinker
4.166600E-01
Non Drinker-vs-Weekly Drinker
4.632600E-01
Non Drinker-vs-Occasional Drinker
4.459600E-01
Non Drinker-vs-Social Drinker
9.762000E-01
Daily Drinker-vs-Weekly Drinker
9.145400E-01
Daily Drinker-vs-Occasional Drinker
9.804200E-01
Daily Drinker-vs-Social Drinker
4.012800E-01
Weekly Drinker-vs-Occasional Drinker
9.018400E-01
Weekly Drinker-vs-Social Drinker
4.806600E-01
Occasional Drinker-vs-Social Drinker
3.943400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.575800E-01
Normal-vs-Grade 2
7.628800E-01
Normal-vs-Grade 3
8.344400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.156900E-04
Grade 1-vs-Grade 3
1.75224999999779E-05
Grade 1-vs-Grade 4
6.575800E-01
Grade 2-vs-Grade 3
6.483800E-02
Grade 2-vs-Grade 4
7.628800E-01
Grade 3-vs-Grade 4
8.344400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.173800E-01
Normal-vs-NonDiabetic
5.881800E-01
Diabetic-vs-NonDiabetic
5.349600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.471000E-01
Normal-vs-NoPancreatitis
6.102000E-01
Pancreatitis-vs-NoPancreatitis
9.327800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.822200E-01
Normal-vs-N1
5.593000E-01
N0-vs-N1
2.738200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.434570E-01
Normal-vs-TP53-NonMutant
7.854200E-01
TP53-Mutant-vs-TP53-NonMutant
7.90710052989141E-10
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
